Business & Regulation

An industry consortium is tackling one of pharma’s biggest drug-related challenges.

We want to hear your thoughts on what mRNA could do for cell and gene therapy

Sitting Down With Dolores Schendel, Chief Executive Officer and Chief Scientific Officer at Medigene.

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March

Enveda Biosciences Founder Viswa Colluru shares the lessons he has learned whilst charting the vast terra incognita of nature’s chemical structure

IFPMA’s Director-General, Thomas Cueni, outlines how companies worldwide can foster long-term tech transfer partnerships.

It’s time for pharma companies to embrace digital technologies.

Companies must adapt to the requirements of rigorous remote inspections.

A report from Clarivate has tipped 7 drugs for potential blockbuster status in 2022. Here’s what makes them stand out.

In this new series, we ask industry leaders in the cell and gene field to answer key questions about the industry.